2014
Buprenorphine/Naloxone Dose and Pain Intensity Among Individuals Initiating Treatment for Opioid Use Disorder
Becker WC, Ganoczy D, Fiellin DA, Bohnert AS. Buprenorphine/Naloxone Dose and Pain Intensity Among Individuals Initiating Treatment for Opioid Use Disorder. Journal Of Substance Use And Addiction Treatment 2014, 48: 128-131. PMID: 25312475, DOI: 10.1016/j.jsat.2014.09.007.Peer-Reviewed Original ResearchConceptsOpioid use disorderNumerical rating scoreBUP/NXPain intensityUse disordersPrimary outcomeBuprenorphine/naloxone doseDecreased pain intensityFull agonist opioidsImproved pain intensityBuprenorphine/naloxoneSubset of patientsSubstance use comorbiditiesChronic pain diagnosesPartial agonist propertiesEligible patientsNX treatmentAgonist opioidsPain levelsNaloxone doseComorbid painMultivariable analysisMaintenance treatmentMean ageClinical correlates
2011
Racial Differences in Primary Care Opioid Risk Reduction Strategies
Becker WC, Starrels JL, Heo M, Li X, Weiner MG, Turner BJ. Racial Differences in Primary Care Opioid Risk Reduction Strategies. The Annals Of Family Medicine 2011, 9: 219-225. PMID: 21555749, PMCID: PMC3090430, DOI: 10.1370/afm.1242.Peer-Reviewed Original ResearchConceptsRegular office visitsUrine drug testingOpioid risk-reduction strategiesWhite patientsBlack patientsOffice visitsRisk reduction strategiesOpioid analgesicsEarly refillsDrug testingGuideline-recommended strategiesOpioids long termChronic noncancer painPrimary care patientsHealth care factorsMixed effects regression modelsRace/ethnicityNoncancer painOpioid refillsMedical comorbiditiesRetrospective cohortCare patientsOpioid misuseCare factorsHigher odds